Pediatric Rheumatology

, 12:P282 | Cite as

Diagnosis of tuberculosis infection in pediatric patients treated with inhibitors of the tumour necrosis factor alpha. A multicenter national study comparing tuberculin skin test and igra tests

  • Antoni Noguera Julian
  • Jordi Antón López
  • Joan Calzada-Hernández
  • Esmeralda Núñez Cuadros
  • Maria José Mellado Peña
  • Francisco Javier Martín Carpi
Open Access
Poster presentation


Tuberculosis Interferon Inflammatory Bowel Disease Pediatric Patient Rheumatic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


In the last years, inhibitors of tumor necrosis factor alpha (antiTNFα) have been a major advance in the treatment of many rheumatic diseases and inflammatory bowel disease, also in the pediatric patient. However, antiTNFα use is associated with an increased risk of serious infections, including tuberculosis (TB). In adults, the new interferon γ release assays (IGRA) tests for the diagnosis of TB infection appear to show better sensitivity and specificity than the tuberculin skin test (TST) in these patients. Data in children are still very scarce. We have previously reported a latent tuberculosis infection (LTI) prevalence rate of 1.4% (95%CI: 0-2.9) in children on antiTNFα treatment, which is similar to that reported in healthy pediatric population studies in Spain. LTI was diagnosed in 3 adolescent girls (out of 221 patients) in whom QTF tested positive, while TST was positive in only one of them.


To establish the sensitivity and specificity of IGRA tests in the diagnosis of LTI compared to the TST in pediatric patients by the implementation of antiTNFα treatment.


We present an ongoing national multicenter retrospective/prospective cross-sectional study (hosted by the Spanish National Societies of Pediatric Rheumatology, Infectious Diseases and Gastroenterology) including pediatric patients in whom LTI is to be ruled out simultaneously by TST and IGRA test, prior to initiating treatment with antiTNFα drugs. Medical history related to the underlying disease, the risk of LTI and the results of the TST and IGRA tests will be collected.


This study will observe the prevalence of LTI in this cohort, identify risk factors associated with LTI and analyze the sensitivity, specificity and negative predictive value of IGRA tests as compared to TST in children before antiTNFα initiation.

Disclosure of interest

None declared.

Copyright information

© Julian et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Antoni Noguera Julian
    • 1
  • Jordi Antón López
    • 2
  • Joan Calzada-Hernández
    • 2
  • Esmeralda Núñez Cuadros
    • 3
  • Maria José Mellado Peña
    • 4
  • Francisco Javier Martín Carpi
    • 5
  1. 1.Pediatric Infectious Diseases Unit, Pediatrics DepartmentHospital Sant Joan de Déu, Esplugues de Llobregat (Barcelona)Spain
  2. 2.Pediatric Rheumatology Unit, Pediatrics DepartmentHospital Sant Joan de Déu, Esplugues de Llobregat (Barcelona)Spain
  3. 3.Hospital Regional Universitario de Málaga (Hospital Carlos Haya)MálagaSpain
  4. 4.Hospital Universitario La Paz, Madrid, Pediatric Gastroenterology DepartmentHospital Sant Joan de Déu, Esplugues de Llobregat (Barcelona)Spain
  5. 5.TBCSpain

Personalised recommendations